Open AccessTriplet Therapy Shows Promise Among Certain Ovarian Cancer Patients
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000723548.30748.2e
Subject(s) - olaparib , medicine , oncology , durvalumab , ovarian cancer , brca mutation , parp inhibitor , cancer , bevacizumab , germline , gynecology , nivolumab , chemotherapy , immunotherapy , biology , biochemistry , polymerase , gene , poly adp ribose polymerase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom